Focused Programs for High-Need Viral Diseases
LuAnce is building a focused portfolio around shared host-directed biology and indication-specific development strategies.
Acute antiviral and post-viral development opportunities
LuAnce programs address coronavirus, licensed Long COVID, dengue, HIV, influenza A/B and emerging viral diseases through a host-directed development strategy.